C30H35N7O4S
589.7 g/mol
Aktif Farmasötik İngredientTehlike
Imatinib mesylate
CAS220127-57-1
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Diğer
Birincil Kullanım
Farmasötik ham madde
Imatinib mesylate is the mesylate salt form of imatinib, a small-molecule tyrosine kinase inhibitor used as an active pharmaceutical ingredient in targeted cancer therapy.
pharmaceutical raw material for tyrosine kinase inhibitor formulationscompound used in manufacturing of oral targeted cancer therapies
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 220127-57-1
İlgili Bileşikler
GüçlüAynı ana yapı
İmatinib
CAS152459-95-5
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.85
N-Desmethyl N-Nitroso Imatinib
CAS2816369-80-7
nitrosamine impurity reference standard
BenzerBenzer yapıBenzerlik 0.85
N-Desmethyl Imatinib
CAS404844-02-6
pharmaceutical metabolite standard
BenzerBenzer yapıBenzerlik 0.81
4-[(4-methyl-4-oxidopiperazin-4-ium-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
CAS571186-91-9
active pharmaceutical ingredient
ReferansAynı kategori
Levocloperastine fendizoate
CAS220329-19-1
active pharmaceutical ingredient
ReferansAynı kategori
AR-C124910XX
CAS220347-05-7
active pharmaceutical ingredient
ReferansAynı kategori
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-Dihydroxysuccinate
CAS220352-39-6
Active pharmaceutical ingredient
ReferansAynı kategori
Rel-(3E,3aR,4R,8bR)-3-[[[(2R)-2,5-Dihydro-4-methyl-5-oxo-2-furanyl]oxy]methylene]-3,3a,4,5,6,7,8,8b-octahydro-4-hydroxy-8,8-dimethyl-2H-indeno[1,2-b]furan-2-one
CAS220493-64-1
active pharmaceutical ingredient reference standard
Güvenlik Referansı
Tehlike
H302Harmful if swallowed
H351Suspected of causing cancer
H360May damage fertility or the unborn child
Tanımlayıcılar
IUPAC Adı
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
InChIKey
YLMAHDNUQAMNNX-UHFFFAOYSA-N
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Eş Anlamlılar (53)
- IMKELDI
- Imatinib mesylate (USAN)
- 220127-57-1 (mesylate)
- CGP 57148B
- Genfatinib
- Gleevac
- Gleevec
- Gleevec (Imatinib mesylate)
- Gleevec (TN)
- Glivec
- Glivec (TN)
- IMATINIB MESILATE [MART.]
- Imatinib (as mesilate)
- Imatinib Mesylate (STI571)
- Imatinib Mesylate Tablets
- Imatinib Mesylate(|A form)
- Imatinib Methansulfonate
- Imatinib accord
- Imatinib medac
- Imatinib mesilate
- Imatinib mesilate (JAN)
- Imatinib mesilate CRS
- Imatinib mesylate
- Imatinib mesylate 400 mg
- Imatinib monomethanesulfonate
- Imatinib(free base)?
- Mesylate, Imatinib
- Methanesulfonate, Imatinib
- ST-1571 Mesylate
- Shantinib
- imatinib methanesulfonate
- imatinib monomesylate
- imatinib oral